ArticleJournal of virology2004

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Lennart Holterman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.